1) Discovery, Synthesis, and Activity Evaluation of Novel Five-Membered Sulfur-Containing Heterocyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo. Journal of Medicinal Chemistry, 2024, Vol 67, Issue 15. DOI 10.1021/acs.jmedchem.4c00443
2) Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance. Journal of Medicinal Chemistry, 2024, Vol 67, Issue 15. DOI 10.1021/acs.jmedchem.4c00593
3) Discovery and Evaluation of Imidazo[2,1-b][1,3,4]thiadiazole Derivatives as New Candidates for α-Synuclein PET Imaging. Journal of Medicinal Chemistry, 2024, Vol 67, Issue 15. DOI 10.1021/acs.jmedchem.4c00686
4) Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP. European Journal of Medicinal Chemistry, 2024, Volume 277, 116708. DOI 10.1016/j.ejmech.2024.116708
5) Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy. Journal of Medicinal Chemistry, 2024, Vol 67, Issue 15. DOI 10.1021/acs.jmedchem.4c00861
6) Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer. Journal of Medicinal Chemistry, 2024, Vol 67, Issue 15. DOI 10.1021/acs.jmedchem.4c01178
7) Discovery of 2-Methyl-5-(1H-pyrazol-4-yl)pyridines and Related Heterocycles as Promising M4 mAChR Positive Allosteric Modulators for the Treatment of Neurocognitive Disorders. Journal of Medicinal Chemistry, 2024, Vol 67, Issue 15. DOI 10.1021/acs.jmedchem.4c01207
Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer. Journal of Medicinal Chemistry, 2024, Vol 67, Issue 15. DOI 10.1021/acs.jmedchem.4c01323